Cheap and Routine

Jay Flatley, the CEO of Illumina, told the UK's Times that by 2019, the genome sequencing of newborns will be routine and that in three to four years a genome sequence should be available for less than $1,000. "The limitations are sociological; when and where people think it can be applied, the concerns people have about misinformation and the background ethics questions," Flatley says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.